Full text loading...
Beta versus gamma dosimetry close to Ir-192 brachytherapy sources
1.R. Waksman, K. A. Robinson, I. R. Crocker, M. B. Gravanis, S. J. Palmer, C. Wang, G. D. Gustavo, and S. B. King III, “Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries,” Circulation 92, 1383–1386 (1995).
2.B. Schopohl, D. Leirmann, L. J. Pohlit, R. Heyrd, G. Strassmann, R. Bauersachs, D. Schulte-Huermann, C. G. Rahl, K. H. Manegold, J. Kollath, and H. D. Bottcher, “ endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience,” Int. J. Radiat. Oncol., Biol., Phys. 36, 835–840 (1996).
3.P. S. Teirstein, V. Massullo, S. Jani, R. J. Russo, D. A. Cloutier, R. A. Schatz, E. M. Guarneri, S. Steuterman, K. Sirkin, S. Norman, and P. Tripuraneti, “Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis,” Circulation 99, 243–247 (1999).
4.R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, “Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group 43,” Med. Phys. 22, 209–234 (1995).
5.D. Baltas, K. Geramani, G. T. Ioannidis, K. Hierholz, B. Rogge, C. Kolotas, K. Muller-Sievers, N. Milickovic, B. Kober, and N. Zampoglou, “Comparison of calibration procedures for high-dose-rate brachytherapy sources,” Int. J. Radiat. Oncol., Biol., Phys. 43, 653–661 (1999).
6.R. Nath, H. Amols, C. Coffey, D. Duggan, S. Jani, Z. Li, M. Schell, C. Soares, J. Whiting, P. E. Cole, I. Crocker, and R. Schwartz, “Intravascular brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 60,” Med. Phys. 26, 119–151 (1999).
7.C. G. Soares, D. G. Halpern, and C. K. Wang, “Calibration and characterization of beta-particle sources for intravascular brachytherapy,” Med. Phys. 25, 339–346 (1998).
8.R. Wang and X. A. Li, “A Monte Carlo calculation of dosimetric parameters of and SS sources for intravascular brachytherapy,” Med. Phys. 27, 2528–2535 (2000).
9.R. Wang and X. A. Li, “Monte Carlo dose calculations of beta-emitting sources for intravascular brachytherapy: a comparison between EGS4, EGSnrc and MCNP,” Med. Phys. 28, 134–141 (2001).
10.P. Karaiskos, P. Papagiannis, A. Angelopoulos, L. Sakelliou, D. Baltas, P. Sandilos, and L. Vlachos, “Dosimetry of wires for LDR interstitial brachytherapy following the AAPM TG-43 dosimetric formalism,” Med. Phys. 28, 156–166 (2001).
11.A. Angelopoulos, P. Baras, L. Sakelliou, P. Karaiskos, and P. Sandilos, “Monte Carlo dosimetry of a new high dose rate brachytherapy source,” Med. Phys. 27, 2521–2527 (2000).
12.G. M. Daskalov, E. Löffler, and J. F. Williamson, “Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source,” Med. Phys. 25, 2200–2208 (1998).
13.J. Borg and D. W. O. Rogers, “Monte Carlo calculations of photon spectra in air for sources,” NRC Reports, PIRS-629r (1999).
14.R. Nath, N. Yue, and L. Liu, “On the depth of penetration of photons and electrons for intravascular brachytherapy,” Cardiovasc. Radiat. Med. 1, 72–79 (2000).
15.J. F. Williamson and Z. Li, “Monte Carlo aided dosimetry of the microselectron pulsed and high dose rate sources,” Med. Phys. 22, 809–819 (1995).
16.P. Karaiskos, A. Angelopoulos, P. Baras, L. Sakelliou, P. Sandilos, K. Dardoufas, and L. Vlachos, “A Monte Carlo investigation of the dosimetric characteristics of the VariSource high dose rate brachytherapy source,” Med. Phys. 26, 1498–1502 (1999).
17.F. Ballester, C. Hernandez, J. Perez-Calatayud, and F. Lliso, “Monte Carlo calculation of dose rate distributions around wires,” Med. Phys. 24, 1221–1228 (1997).
18.P. Karaiskos, L. Sakeliou, P. Sandilos, and L. Vlachos, “Limitations of the point and line source approximations for the determination of geometry factors around brachytherapy sources,” Med. Phys. 27, 124–128 (2000).
19.M. Piessens and N. Reynaert, “Verification of absolute dose rates for intravascular brachytherapy beta sources,” Phys. Med. Biol. 45, 2219–2231 (2000).
20.J. F. Briesmeister, “MCNP—A general purpose Monte Carlo -Particle transport code, version 4B,” LA-12625-M, Los Alamos National Laboratory (1997).
21.A. Angelopoulos, A. Perris, K. Sakellariou, L. Sakelliou, K. Sarigiannis, and G. Zarris, “Accurate Monte Carlo calculations of the combined attenuation and build-up factors, for energies (20-1500keV) and distances (0-10 cm) relevant in brachytherapy,” Phys. Med. Biol. 36, 763–778 (1991).
22.L. Sakelliou, K. Sakellariou, K. Sarigiannis, A. Angelopoulos, A. Perris, and G. Zarris, “Dose rate distributions around (models 6702 and 6711) brachytherapy sources and the nuclide ” Phys. Med. Biol. 37, 1859–1872 (1992).
23.P. Karaiskos, A. Angelopoulos, L. Sakelliou, P. Sandilos, C. Antypas, L. Vlachos, and E. Koutsouveli, “Monte Carlo and TLD dosimetry of an high dose-rate brachytherapy source,” Med. Phys. 25, 1975–1984 (1998).
24.C. Janicki, D. M. Duggan, C. W. Coffey, D. R. Fischell, and T. A. Fischell, “Radiation dose from a phosphorous-32 impregnated wire mesh vascular stent,” Med. Phys. 24, 437–445 (1997).
25.W. V. Prestwich, J. Nunes, and C. S. Kwok, “Beta dose point kernels for radionuclides of potential use in radioimmunotherapy,” J. Nucl. Med. 30, 1036–1046 (1989).
26.S. Vynckier and A. Wambersie, “Dosimetry of beta sources in radiotherapy I. The beta point source dose function,” Phys. Med. Biol. 27, 1339–1347 (1982).
27.Z. Xu, G. Yang, L. E. Reinstein, and P. E. Cole, “Calculation of dose distribution near an innovative concentric balloon catheter for endovascular brachytherapy,” Cardiovasc. Radiat. Med. 2, 26–31 (2000).
28.D. Baltas, S. Giannouli, A. Garbi, F. Diakonos, K. Geramani, G. T. Ioannidis, A. Tsalpatouros, N. Uzunoglu, C. Kolotas, and N. Zamboglou, “Application of the Monte Carlo integration (MCI) method for calculation of the anisotropy of brachytherapy sources,” Phys. Med. Biol. 43, 1783–1801 (1998).
29.J. H. Hubbel and S. M. Seltzer, “Tables of x-ray mass attenuation coefficients and mass energy-absorption coefficients 1 keV to 20 MeV for elements to 92 and 48 additional substances of dosimetric interest,” NISTIR 5632 (1995).
30.G. P. Glasgow and L. T. Dillman, “Specific-ray constant and exposure rate constant for ” Med. Phys. 6, 49–52 (1979).
31.J. H. Scofield, “Theoretical photoionization cross sections from 1 to 1500 keV,” Lawrence Livenmore Laboratory Report UCRL-51326 (1973).
32.J. H. Hubbel and I. Overbo, “Relativistic atomic form factors and photon coherent scattering cross sections,” J. Phys. Chem. Ref. Data 8, 69–105 (1979).
33.J. H. Hubbel, Wm. J. Veigele, E. A. Briggs, R. T. Brown, D. T. Cromer, and R. J. Howerton, “Atomic form factors, incoherent scattering functions, and photon scattering cross sections,” J. Phys. Chem. Ref. Data 4, 471–538 (1975).
34.E. B. Saloman, J. H. Hubbel, and J. H. Scofield, “X-ray attenuation cross sections for energies 100 eV to 100 keV and elements to ” At. Data Nucl. Data Tables 38, 1–197 (1988).
35.ICRU, Stopping Powers for Electrons and Positrons, ICRU Report 37 (ICRU, Bethesda, MD, 1974).
36.W. G. Cross, H. Ing, and N. Freedman, “A short atlas of beta decay spectra,” Phys. Med. Biol. 28, 1251–1260 (1983).
37.R. Wang, X. A. Li, and C. X. Yu, “Evaluation of EGS4/PRESTA multiple-scattering algorithms for intravascular brachytherapy dosimetry,” Phys. Med. Biol. 45, 2343–2352 (2000).
38.S. Ye, X. A. Li, J. R. Zimmer, J. C. Chu, and C. K. Choi, “Dosimetric perturbations of linear array of β-emitter seeds and metallic stent in intravascular brachytherapy,” Med. Phys. 27, 374–380 (2000).
39.F. A. Mourtada, C. G. Soares, S. M. Seltzer, and S. H. Lott, “Dosimetry characterization of catheter-based vascular brachytherapy source wire,” Med. Phys. 27, 1770–1776 (2000).
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Article metrics loading...